NCT06476834View on ClinicalTrials.gov

A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

November 2, 2024

Study Completion Date

November 2, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

Deucravacitinib

Specified dose on specified days

Trial Locations (1)

89113-2246

Local Institution - 0001, Las Vegas

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06476834 - A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants | Biotech Hunter | Biotech Hunter